Sign up
Quantellect · Congress · Trade Detail
PINK: ALPMYAstellas Pharma Inc
DemocratHouse

Daniel S. Goldman sold Astellas Pharma Inc (PINK: ALPMY)

Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 3 trades in Astellas Pharma Inc (ALPMY) since 2023, 1 purchase and 2 sales, worth an estimated $73K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Daniel S. Goldman sold $15,001 - $50,000 of Astellas Pharma Inc (PINK: ALPMY) on July 10, 2023. Since that trade, ALPMY is up +13.63% against the S&P 500 up +71.78%, an outperformance of -58.14%.

Across these filings, Daniel S. Goldman has been a net seller of ALPMY (a buy-to-sell ratio of 0.50). Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ALPMY trades
3
Disclosed Vol
$73K
Buys
1
33%
Sells
2
67%
Buy / Sell
0.50
ratio
First → Last
2023

Daniel S. Goldman's ALPMY trades vs the price

ALPMY is up +13.63% since Daniel S. Goldman sold on July 10, 2023, versus +71.78% for the S&P 500.

Performance since this trade

Price change since trade
+13.63%
S&P 500 change since trade
+71.78%
Outperformance vs S&P 500
-58.14%

All Daniel S. Goldman ALPMY trades

TradedTypeSizeReturnEst. profit
July 10, 2023SELL$12.26+13.63%
February 27, 2023BUY$11.73+18.75%-$455
January 13, 2023SELL$12.29+13.38%

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Daniel S. Goldman & ALPMY trading FAQ

Is it legal for Daniel S. Goldman to trade Astellas Pharma Inc (ALPMY) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Astellas Pharma Inc (ALPMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Daniel S. Goldman sell ALPMY?

Daniel S. Goldman disclosed a sale of $15,001 - $50,000 of Astellas Pharma Inc (ALPMY) on July 10, 2023, according to public STOCK Act filings.

How has ALPMY performed since Daniel S. Goldman's trade?

Since Daniel S. Goldman sold ALPMY on July 10, 2023, the stock is up +13.63%, versus +71.78% for the S&P 500 over the same period, an outperformance of -58.14%.

How many times has Daniel S. Goldman traded ALPMY?

Daniel S. Goldman has disclosed 3 ALPMY trades since 2023 (1 purchase and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ALPMY trades?

Quantellect tracks every disclosed congressional trade in Astellas Pharma Inc (ALPMY) on the Astellas Pharma Inc congressional trading page, which aggregates filings across all members of Congress.

Daniel S. Goldman's ALPMY tradesAll congressional filings for Astellas Pharma IncDaniel S. Goldman's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.